BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
CLSA maintains buy on Lupin
Expect a pick-up in Lupin Japan business. US generic business may grow at a CAGR (Compound Annual Growth Rate) of 26 per cent. Strong cash flow of the company will lead to higher valuation.